SciSparc Ltd. Announces Promising Phase IIb Trial Results for SCI-110 in Tourette Syndrome
Nov 14, 2023
Tourette Investment Portfolios
SciSparc's SCI-110 Shows Promise in Phase IIb Trial for Tourette Syndrome
Nov 13, 2023